Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (0K6R.L) Stock Overview
Explore Neurocrine Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
13.4B
P/E Ratio
38.52
EPS (TTM)
$0.73
ROE
0.13%
0K6R.L Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Neurocrine Biosciences, Inc. (0K6R.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 63.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $135.24.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 38.52 and a market capitalization of 13.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.